XIGRIS 5mg powder infusion solution medication leaflet

B01AD10 • drotrecogine alfa • Blood and blood forming organs | Antithrombotic agents | Enzymes

Drotrecoginum alfa was a medication previously used for the treatment of severe sepsis with multiple organ dysfunction. It is a recombinant activated protein C that works by reducing inflammation and excessive coagulation, thereby improving blood flow and organ function.

The medication was administered intravenously, usually in a hospital setting, under medical supervision. It was used to reduce mortality associated with severe sepsis.

Side effects included bleeding, allergic reactions, and, in rare cases, severe hemorrhages. Its use has been discontinued in many countries due to limited efficacy and associated risks.

Consult your doctor to discuss available alternatives for the treatment of severe sepsis. Follow all medical recommendations to ensure the best possible care.